1. Articles in category: Blog

    1-5 of 5
    1. CHLA Researcher Awarded $1.9 Million by NIH to Study Novel Approach to Battling Neuroblastoma

      CHLA Researcher Awarded $1.9 Million by NIH to Study Novel Approach to Battling Neuroblastoma

      Muller Fabbri, MD, PhD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, has been awarded $1.9 million by the National Cancer Institute of the NIH to further his research on neuroblastoma.

      Read Full Article
    2. The rocky road to developing new children’s cancer treatments

      The rocky road to developing new children’s cancer treatments

      It takes years to develop drugs that target a specific cancer-causing mutation. Dr Claire Bithell reflects on the promises of targeting ALK mutations in neuroblastoma – a common type of childhood cancer. There was great excitement when researchers linked cancer-causing gene ALK to a children’s cancer called neuroblastoma back in 2008. Although we live in an era of personalised medicine for many adult cancers, progress has been much slower in children.

      Read Full Article
      Mentions: ALK
    3. How we're fighting neuroblastoma

      A new storyline in Coronation Street will help to raise awareness about neuroblastoma – a devastating cancer which often affects very young children. Henry French writes on how this awareness could improve treatment for this disease and other childhood cancers. Neuroblastoma is a major focus for research led by our childhood cancer experts here at the ICR.

      Read Full Article
    1-5 of 5
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Drug Development, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Popular Articles